tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
PACB is currently covered by 8 analysts with an average price target of $3.24. This is a potential upside of $1.22 (60.4%) from yesterday's end of day stock price of $2.02.
Pacific Biosciences of California's activity chart (see below) currently has 131 price targets and 95 ratings on display. The stock rating distribution of PACB is 56.25% HOLD and 43.75% BUY.
Analysts average stock forecasts to be materialized ratio is 61.03% with an average time for these price targets to be met of 242.31 days.
Highest price target for PACB is $3, Lowest price target is $1.5, average price target is $1.98.
Most recent stock forecast was given by DAVID WESTENBERG from PIPER SANDLER on 10-Aug-2025. First documented stock forecast 27-Aug-2015.
Currently out of the existing stock ratings of PACB, 9 are a HOLD (56.25%), 7 are a BUY (43.75%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$1.5
$-0.14 (-8.54%)
$1.25
2 months 14 days ago
(10-Aug-2025)
8/10 (80%)
$0.24 (19.05%)
127
Hold
$1.5
$-0.14 (-8.54%)
$2
4 months ago
(24-Jun-2025)
6/6 (100%)
$0.28 (22.95%)
14
Buy
$1.8
$0.16 (9.76%)
$2.5
5 months 10 days ago
(14-May-2025)
0/3 (0%)
$0.74 (69.81%)
Buy
$3
$1.36 (82.93%)
$4
5 months 16 days ago
(08-May-2025)
1/3 (33.33%)
$1.88 (167.86%)
40
Buy
$3
$1.36 (82.93%)
$3
6 months 15 days ago
(09-Apr-2025)
5/13 (38.46%)
$1.62 (117.39%)
123
What is PACB (Pacific Biosciences of California) average time for price targets to be met?
Which analyst has the current highest performing score on PACB (Pacific Biosciences of California) with a proven track record?
Which analyst has the most public recommendations on PACB (Pacific Biosciences of California)?
Which analyst is the currently most bullish on PACB (Pacific Biosciences of California)?
Which analyst is the currently most reserved on PACB (Pacific Biosciences of California)?
